Latest news
Insmed's Explosive Quarter Reshapes the Debate: Momentum vs. Valuation - AD HOC NEWSAD HOC NEWS · Sun, 09 Aug 2026 16:12:16 GMTInsmed's Quarter Rewrites the Script, But the Charts Tell a More Complicated Story - AD HOC NEWSAD HOC NEWS · Sun, 09 Aug 2026 15:22:12 GMTInsmed's Growth Story Reaches an Inflection Point as BRINSUPRI Momentum Accelerates - AD HOC NEWSAD HOC NEWS · Sat, 08 Aug 2026 15:33:27 GMTInsmed's Pivot From Cash Burn to Cash Flow: What the 32% Weekly Surge Really Means - AD HOC NEWSAD HOC NEWS · Sat, 08 Aug 2026 15:03:23 GMTMatt Phipps Reiterates Buy on Insmed as Brinsupri Outperformance, Raised Guidance and Higher Peak Sales Outlook Strengthen Long-Term Growth Story - TipRanksTipRanks · Thu, 06 Aug 2026 18:36:05 GMTInsmed Stock Pops As Analysts Hike Price Targets On TPIP, Brinsupri Momentum - StocksToTradeStocksToTrade · Thu, 06 Aug 2026 16:35:00 GMTInsmed Raises BRINSUPRI Revenue Guidance After Strong Q2 Growth and Expands Peak Sales Outlook - finance.yahoo.comfinance.yahoo.com · Thu, 06 Aug 2026 14:56:01 GMTInsmed Q2 2026 Earnings: BRINSUPRI Drives $425.5 Million in Revenue - TradingKeyTradingKey · Thu, 06 Aug 2026 11:18:54 GMT